Healthcare Oriza-backed Chinese Biotechnology Firm Ascentage Pharma Files For Hong Kong IPO August 21, 2018 — 11:01
Investment Bioventure Leads Series A+ Round In Antiviral Drugs Maker Ark Biosciences February 6, 2017 — 14:13